Abiopharma

New Form 10-K - BIOMERICA INC Filed: 2025-08-29 AccNo: 0001641172-25-026041 Size: 7 MB

New Form 8-K - Enveric Biosciences, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026040 Size: 206 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 8-K - EXELIXIS, INC. Filed: 2025-08-29 AccNo: 0000939767-25-000115 Size: 273 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - Odyssey Health, Inc. Filed: 2025-08-29 AccNo: 0001683168-25-006584 Size: 686 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form S-3 - Inotiv, Inc. Filed: 2025-08-29 AccNo: 0001628280-25-041413 Size: 1 MB

New Form PRE 14A - Autonomix Medical, Inc. Filed: 2025-08-29 AccNo: 0001437749-25-028052 Size: 1 MB

New Form 8-K - Canopy Growth Corp Filed: 2025-08-29 AccNo: 0001104659-25-085779 Size: 905 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Hohl Benjamin 🟡 adjusted position in 3.2K shares (1 derivative) of Enliven Therapeutics, Inc. (ELVN) at $20.63 Transaction Date: Aug 27, 2025 | Filing ID: 023310

New Form 144 - AGENUS INC Filed: 2025-08-29 AccNo: 0000950170-25-112266 Size: 5 KB

New Form 144 - MiNK Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0000950170-25-112266 Size: 5 KB

New Form 8-K - Stereotaxis, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026031 Size: 559 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 8-K - Akari Therapeutics Plc Filed: 2025-08-29 AccNo: 0001641172-25-026032 Size: 771 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item …

New Form S-3 - Tivic Health Systems, Inc. Filed: 2025-08-29 AccNo: 0001683168-25-006582 Size: 544 KB

Canopy Growth Communication - Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company’s Financial Position

New Form 8-K - TAO Synergies Inc. Filed: 2025-08-29 AccNo: 0001104659-25-085770 Size: 211 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits